Peter J. Kelly

ORCID: 0000-0003-4772-6565
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Atrial Fibrillation Management and Outcomes
  • Stroke Rehabilitation and Recovery
  • Venous Thromboembolism Diagnosis and Management
  • Atherosclerosis and Cardiovascular Diseases
  • Inflammasome and immune disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Lipoproteins and Cardiovascular Health
  • Folate and B Vitamins Research
  • Intracranial Aneurysms: Treatment and Complications
  • Cardiovascular Health and Disease Prevention
  • Peripheral Artery Disease Management
  • Cardiac Arrhythmias and Treatments
  • Clinical practice guidelines implementation
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Imaging and Diagnostics
  • Adipokines, Inflammation, and Metabolic Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Acute Myocardial Infarction Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cerebral Venous Sinus Thrombosis
  • Dementia and Cognitive Impairment Research
  • Healthcare Systems and Practices

Mater Misericordiae University Hospital
2016-2025

University College Dublin
2016-2025

Health Research Board
2017-2025

Cancer Trials Ireland
2024

Biomedical Research Institute
2024

Hospital de Sant Pau
2022-2024

University College London
2024

University College Cork
2024

St. Vincent's University Hospital
2014-2024

Cork University Hospital
2005-2024

After a transient ischemic attack (TIA) or minor stroke, the long-term risk of stroke and other vascular events is not well known. In this follow-up to report on 1-year outcomes from registry TIA clinics in 21 countries that enrolled 4789 patients with 2009 through 2011, we examined 5-year events.

10.1056/nejmoa1802712 article EN New England Journal of Medicine 2018-05-16

Symptomatic carotid stenosis is associated with a 3-fold risk of early stroke recurrence compared to other subtypes. Current imaging techniques rely on estimating plaque-related lumen narrowing but do not evaluate intraplaque inflammation, key mediator plaque rupture and thromboembolism. Using combined (18) F-fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography, we investigated the relation between inflammation-related FDG uptake recurrence.Consecutive patients...

10.1002/ana.23553 article EN Annals of Neurology 2012-02-01
Mayowa Owolabi Amanda G. Thrift Sheila Cristina Ouriques Martins Walter D. Johnson Jeyaraj Pandian and 95 more Foad Abd-Allah Cherian Varghese Ajay Mahal Joseph Yaria Hoang Phan Gregory A. Roth Seana Gall Richard Beare Thanh G. Phan Robert Mikulík Bo Norrving Valery L. Feigin Semaw Ferede Abera Adamu Addissie Adeniyi Adeleye Yerzhan Adilbekov B. Adilbekova Thierry Adoukonou de Aguiar З Б Ахметжанова Rufus Akinyemi Albert Akpalu Sebastián Ameriso Silva Andonova Carlos Abanto Folorunso E Awoniyi Moiz Bakhiet Helmi Hasan Basri Philip M. Bath Dániel Bereczki Simone Beretta Aaron L. Berkowitz Julie Bernhardt Guna Bērziņa Bhavan Bhavsar Mher S Bisharyan Pascal Bovet Michael Brainin Hrvoje Budinčević Norberto L. Cabral Dominique A. Cadilhac Valeria Caso Christopher Chen Joong Hyoun Chin Hanne Christensen Kamil Chwojnicki Adriana Bastos Conforto Vítor Tedim Cruz Marco D’Amelio Kristine Edgar Danielyan Stephen M. Davis Vida Demarin Robert J. Dempsey Martin Dichgans Dokova Geoffrey A. Donnan Juan Carlos Durán Marcelo Elizondo Mitchell S Elkind Matthias Endres I. Etedal MoezAlIslam E. Faris Urs Fischer Fortuné Gbètoho Gankpé Martín Gavidia A. Gaye-Saavedra Maurice Giroud Fernando Góngora‐Rivera Vladimir Hachinski Werner Hacke Randah R Hamadeh Talhatu K. Hamzat Graeme J. Hankey Mirjam R. Heldner Norlinah Mohamed Ibrahim Manami Inoue Sun Ha Jee Jeng Jiann-Shing S. Claiborne Johnston Yogeshwar Kalkonde Saltanat Kamenova Peter J. Kelly Tariq Khan Stefan Kiechl Аida Kondybayeva Janika Kõrv Maksim Kravchenko Rita Krishnamurthi Peter Langhorne Zijian Kang Jera Kruja Pablo M. Lavados Dmytro Lebedynets Thomas Leung David S Liebeskind

Improving stroke services is critical for reducing the global burden. The World Stroke Organization-World Health Organization-Lancet Neurology Commission on conducted a survey of status in low and middle-income countries (LMICs) compared to high-income countries.Using validated Organization comprehensive questionnaire, we collected data along four pillars quadrangle (surveillance, prevention, acute stroke, rehabilitation) 84 across regions economic strata. also non-communicable diseases 194...

10.1177/17474930211019568 article EN International Journal of Stroke 2021-05-14

The effect of early as compared with later initiation direct oral anticoagulants (DOACs) in persons atrial fibrillation who have had an acute ischemic stroke is unclear.We performed investigator-initiated, open-label trial at 103 sites 15 countries. Participants were randomly assigned a 1:1 ratio to anticoagulation (within 48 hours after minor or moderate on day 6 7 major stroke) (day 3 4 stroke, 12, 13, 14 stroke). Assessors unaware the trial-group assignments. primary outcome was composite...

10.1056/nejmoa2303048 article EN New England Journal of Medicine 2023-05-24
Shelagh B. Coutts Sandeep Ankolekar Ramana Appireddy Juan F. Arenillas Zarina Assis and 95 more Peter Bailey Philip A. Barber Rodrigo Bazán Brian Buck Kenneth Butcher Marie‐Christine Camden Bruce Campbell Leanne K. Casaubon Luciana Catanese Kausik Chatterjee Philip Choi Brian Clarke Dar Dowlatshahi Julia Ferrari Thalia S. Field Aravind Ganesh Darshan Ghia Mayank Goyal Stefan Greisenegger Omid Halse MacKenzie Horn Gary Hunter Oje Imoukhuede Peter J. Kelly James Kennedy Carol Kenney Timothy Kleinig Kailash Krishnan Fabrício Oliveira Lima Jennifer Mandzia Martha Marko Sheila Cristina Ouriques Martins George Medvedev Bijoy K. Menon Sachin Mishra Carlos A. Molina Aimen Moussaddy Keith W. Muir Mark Parsons Andrew M W Penn Arthur Pille Octávio Marques Pontes‐Neto Christine Roffe Joaquı́n Serena Robert Simister Nishita Singh Neil J. Spratt Daniel Strbian Carol Huilian Tham M Ivan Wiggam David Williams M Willmot Teddy Y. Wu Amy Yu George Zachariah Atif Zafar Charlotte Zerna Michael D. Hill Marina Salluzzi Nicole Blenkin Ashley Dueck Craig Doram Qiao Zhang Carol Kenney Karla J. Ryckborst Shelly Bohn Quentin Collier Frances Taylor Brendan Cord Lethebe Anitha Jambula Kayla Sage Lana Toussaint Supryia Save Jaclyn Lee Nihay Laham-Karam Asfia Sultan Deepak Agrawal A Sitaram Andrew M. Demchuk Andrew Lockey A. Micielli Ankur Wadhwa Babawale Arabambi B Graham Chrysi Bogiatzi Darshan Doshi Debabrata Chakraborty Diana Kim Denise Vasquez D Singh Dominic Tse Earl C. Harrison Eric E. Smith Erika Teleg Evgenia Klourfeld

10.1016/s0140-6736(24)00921-8 article EN The Lancet 2024-05-17

Background: Inflammatory bowel diseases have significant long‐term morbidity and healthcare resource consequences. Studies based on secondary care records may underestimated the contribution of general practitioners (GPs) to its management. Aims: To describe epidemiology management inflammatory disease using GP as primary data source. Methods: A systematic search clinical in northern England, identifying cases disease, patient consultation behaviour, prescribing patterns, extent specialist...

10.1046/j.1365-2036.2000.00886.x article EN Alimentary Pharmacology & Therapeutics 2000-12-27

Experimental stroke studies indicate that oxidative stress is a major contributing factor to ischemic cerebral injury. Oxidative also implicated in activation of matrix metalloproteinases (MMPs) and blood-brain barrier injury after ischemia-reperfusion. Plasma biomarkers may have utility as early indicators efficacy Phase 2 trials antioxidant therapies human stroke. To date, valid biomarker has been unavailable. We measured F2-isoprostanes (F2IPs), free-radical induced products neuronal...

10.1161/strokeaha.107.488189 article EN Stroke 2007-12-07

<i>Background:</i> Prospective population-based studies are important to accurately determine the incidence and characteristics of stroke associated with atrial fibrillation (AF), while avoiding selection bias which may complicate hospital-based studies. <i>Methods:</i> We investigated AF-associated within North Dublin Population Stroke Study, a prospective cohort study stroke/transient ischaemic attack in 294,592 individuals, according recommended criteria for...

10.1159/000255973 article EN Cerebrovascular Diseases 2009-11-05

Background and Purpose— Reliable etiologic classification of ischemic stroke may enhance clinical trial design identification subtype-specific environmental genetic risk factors. Although new systems (Causative Classification System [CCS] ASCO [A for atherosclerosis, S small vessel disease, C cardiac source, O other cause]) have been developed to improve subtype assignment, few comparative data exist from large studies. We hypothesized that both CCS would reduce the proportion patients...

10.1161/strokeaha.109.575373 article EN Stroke 2010-07-02

Matrix metalloproteinase-9 (MMP9) is expressed in acute ischemic stroke and up-regulated by tissue plasminogen activator (tPA) animal models. The authors investigated plasma MMP9 its endogenous inhibitor, inhibitor of metalloproteinase (TIMP1), tPA-treated -untreated patients.Nonstroke control subjects consecutive patients presenting within 8 hours onset were enrolled. Blood was sampled at 24 hours, 2 to 5 days 4 6 weeks. TIMP1 analyzed ELISA gel zymography.Fifty-two cases (26 tPA treated,...

10.1212/01.wnl.0000216133.98416.b4 article EN Neurology 2006-05-01

Background and Purpose— The ABCD system was developed to predict early stroke risk after transient ischemic attack. Incorporation of brain imaging findings has been suggested, but reports have used inconsistent methods underpowered. We therefore performed an international, multicenter collaborative study the prognostic performance 2 score infarction on determine optimal weighting in (ABCD I). Methods— Twelve centers provided unpublished data scores, presence either diffusion-weighted or CT,...

10.1161/strokeaha.110.578971 article EN Stroke 2010-07-16

Background and Purpose— Although symptomatic carotid stenosis is associated with 3-fold increased risk of early stroke recurrence, the pathophysiologic mechanisms high have not been established. We aimed to investigate relationship between recurrence after initial symptoms histological features plaque inflammation instability in resected plaque. Methods— Carotid endarterectomy tissue from consecutive patients ipsilateral ≥50% recent were analyzed using a validated histopathologic algorithm...

10.1161/strokeaha.113.003657 article EN Stroke 2014-01-31

The aim of the present European Stroke Organisation Transient Ischaemic Attack (TIA) management guideline document is to provide clinically useful evidence-based recommendations on approaches triage, investigation and secondary prevention, particularly in acute phase following TIA. guidelines were prepared Standard Operational Procedure for a according GRADE methodology. As basic principle, we defined TIA pragmatically generalisability as transient neurological symptoms, likely be due focal...

10.1177/2396987321992905 article EN European Stroke Journal 2021-03-16

Background and Purpose- Plaque inflammation contributes to stroke coronary events. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) identifies plaque inflammation-related metabolism. Almost no prospective data exist on the relationship of carotid 18F-FDG uptake early recurrent stroke. Methods- We did a multicenter cohort study BIOVASC (Biomarkers/Imaging Vulnerable Atherosclerosis in Symptomatic Carotid disease) patients with stenosis recent stroke/transient ischemic attack...

10.1161/strokeaha.119.025422 article EN Stroke 2019-06-06
Coming Soon ...